Citations

Clear

464 citation(s) found for "Josephs, Keith A".

Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer’s Disease Neuropathological Changes
Buciuc, Marina , Wennberg, Alexandra , Weigand, Stephen D. , Murray, Melissa E. , Senjem, Matthew L. , Spychalla, Anthony J., Jack, Clifford R. , Kantarci, Kejal , Parisi, Joseph E., Petersen, Ronald C. , Whitwell, Jennifer L. , Josephs, Keith A. , Wennberg, Alexandra M, Jack, Clifford R , Wennberg, Alexandra M V , Buciuc, Marina , Senjem, Matthew L , Kantarci, Kejal , Murray, Melissa E , Boeve, Bradley F. , Knopman, David S. , Dickson, Dennis W.

Mayo Clinic

Journal of Alzheimer’s Disease | January 10, 2020 | Volume: 73 | Issue: 4 | Pages: 1511-1523

10.3233/jad-191040 | PMID 31929165 Get It

Background: Transactive response DNA-binding protein of 43 kDa (TDP-43) is associated with hippocampal atrophy in Alzheimer’s disease (AD), but whether the association is modified by other factors is unknown. Objective: To evaluate whether the associations between TDP-43 and hippocampal volume and atrophy rate are affected by age, gender, apolipoprotein E ( APOE) ɛ4, Lewy bodies (LBs), amyloid-β (Aβ), or Braak neurofibrillary tangle (NFT) stage. Methods: In this longitudinal neuroimaging-clinicopathological study of 468 cases with AD neuropathological changes (Aβ-positive) that had completed antemortem head MRI, we investigated how age, gender, APOE ɛ4, presence of LBs, Aβ, TDP-43, and Braak NFT stages are associated with hippocampal volumes and rates of atrophy over time. We included field strength in the models since our cohort included 1.5T and 3T scans. We then determined whether the associations between hippocampal atrophy and TDP-43 are modified by these factors using mixed effects models. Results: Older age, female gender, APOE ɛ4, higher field strength, higher TDP-43, and Braak NFT stages were associated with smaller hippocampi. Rate of atrophy was greater with higher TDP-43 and Braak NFT stage, but lower in older patients. The association of TDP-43 with greater rate of atrophy was enhanced in APOE ɛ4 carriers ( p = 0.04). Conclusion: Neurodegenerative effects of TDP-43 seem to be independent of most factors except perhaps APOE in cases with AD neuropathological changes. TDP-43 and tau appear to behave independently of one another.
In Vivo Imaging and Autoradiography in a Case of Autopsy-Confirmed Pick Disease
Murray, Melissa E. , Tranovich, Jessica F., Scott, Nancy E. , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Murray, Melissa E , Utianski, Rene L. , Schwarz, Christopher G.

Mayo Clinic

Neurology Clinical Practice | January 6, 2020 | Volume: 11 | Issue: 1 | Pages: No page available

10.1212/cpj.0000000000000755 | PMID 33968481 Get It

PSP-like syndrome after aortic surgery in adults (Mokri syndrome)
Tisel, Sarah M. , Ahlskog, J. Eric , Matsumoto, Joseph Y., Josephs, Keith A. , Duffy, Joseph R.

Mayo Clinic

Neurology Clinical Practice | January 6, 2020 | Volume: 10 | Issue: 3 | Pages: 245-254

10.1212/cpj.0000000000000708 | PMID 32642326 Get It

Incidence of frontotemporal disorders in Olmsted County: A population‐based study
Turcano, Pierpaolo , Stang, Cole , Martin, Peter R. , Upadhyaya, Sudhindra, Josephs, Keith A. , Petersen, Ronald C. , Savica, Rodolfo , Stang, Cole D., Upadhyaya, Sudhindra G, Mielke, Michelle M. , Boeve, Bradley F. , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | November 26, 2019 | Volume: 16 | Issue: 3 | Pages: 482-490

10.1016/j.jalz.2019.08.199 | PMID 31784373 Get It

AbstractIntroductionFrontotemporal dementia disorders (FTDs) are heterogeneous phenotypical behavioral and language disorders usually associated with frontal and/or temporal lobe degeneration. We investigated their incidence in a population‐based cohort.MethodsUsing a records‐linkage system, we identified all patients with a diagnostic code for dementia in Olmsted County, MN, 1995–2010, and confirmed the diagnosis of FTD. A behavioral neurologist verified the clinical diagnosis and determined phenotypes.ResultsWe identified 35 FTDs cases. Overall, the incidence of FTDs was 4.3/100,000/year (95% CI: 2.9, 5.7). Incidence was higher in men (6.3/100,000, 95% CI 3.6, 9.0) than women (2.9/100,000; 95% CI: 1.3, 4.5); we observed an increased trend over time (B = 0.83, 95% CI: 0.54, 1.11, P < .001). At autopsy, clinical diagnosis was confirmed in eight (72.7%) cases.DiscussionWe observed an increased incidence and trends of FTDs over time. This may reflect a better recognition by clinicians and improvement of clinical criteria and diagnostic tools.
Western Aphasia Battery–Revised Profiles in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech
Botha, Hugo , Josephs, Keith A. , Whitwell, Jennifer L. , Strand, Edythe A. , Botha, Hugo , Clark, Heather M. , Utianski, Rene L. , Duffy, Joseph R.

Mayo Clinic

American Journal of Speech-Language Pathology | October 23, 2019 | Volume: 29 | Issue: 1S | Pages: 498-510

10.1044/2019_ajslp-cac48-18-0217 | PMID 31639312 Get It

Purpose The primary aim was to examine the utility of the Western Aphasia Battery–Revised (WAB-R; Kertesz, 2007 ) for classifying variants of primary progressive aphasia (PPA). Traditional WAB-R metrics of Aphasia Quotient (AQ), subtest scores, WAB-R classification, and several novel metrics were examined. A secondary aim was to examine these same WAB-R metrics in individuals with primary progressive apraxia of speech (PPAOS). Method A retrospective analysis of WAB-R records from 169 participants enrolled in a study of neurodegenerative speech and language disorders was conducted. PPA/PPAOS classification was determined by consensus review of speech, language, and cognitive profiles. Scores on each of the WAB-R subtests were obtained to derive AQ, WAB-R aphasia profile, and 3 ratios reflecting relative performance on subtests. Results Mean AQ was significantly higher in the PPAOS group compared to all PPA variants except primary fluent aphasia. AQ above the normal cutoff was observed for 20% of participants with PPA. Significant main effects of group were noted for each of the subtests. Follow-up comparisons most frequently discriminated PPAOS, primary agrammatic aphasia (PAA), and logopenic progressive aphasia. Primary fluent aphasia and semantic dementia (SD) subtest scores were less distinctive, with the exception of Naming for SD, which was significantly lower than for PAA and PPAOS. When the WAB-R AQ detected aphasia, a classification of anomic aphasia was most frequently observed; this pattern held true for each of the PPA variants. The mean Information Content:Naming ratio was highest for SD, and the mean Comprehension:Fluency ratio was highest for PAA. Conclusions In the current study, AQ underestimated the presence of PPA and WAB-R classification did not distinguish among PPA classification determined by consensus. Performance on individual subtests and relative performance across subtests demonstrated inconsistent alignment with PPA classification. We conclude the WAB-R in isolation is inadequate to detect or characterize PPA. We instead suggest utilizing the WAB-R as 1 component of a comprehensive language and motor speech assessment when PPA is suspected.
DT‐02‐01: REPURPOSING FDG‐PET AS A DIAGNOSTIC TOOL FOR ALZHEIMER'S‐RELATED TDP‐43‐PROTEINOPATHY
Petersen, Ronald C. , Petrucelli, Leonard , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Buciuc, Marina , Botha, Hugo , Murray, Melissa E. , Jones, David T. , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_28 | Pages: No page available

10.1016/j.jalz.2019.08.010 Get It

O2‐08‐01: ANTE‐MORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON‐FTLD OLDER ADULTS
Martin, Peter R. , Tosakulwong, Nirubol , Petersen, Ronald C. , Parisi, Joseph E., Whitwell, Jennifer L. , Josephs, Keith A. , Bejanin, Alexandre , Murray, Melissa E. , Botha, Hugo , Schwarz, Christopher G. , Senjem, Matthew L. , Chételat, Gaël , Jack, Clifford R. , Boeve, Bradley F. , Knopman, David S. , Giannini, Caterina , Dickson, Dennis W. , Whitwell, Jennifer L.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2019.06.4493 Get It

IC‐04‐02: ANTEMORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON‐FTLD OLDER ADULTS
Martin, Peter R. , Tosakulwong, Nirubol , Petersen, Ronald C. , Parisi, Joseph E., Whitwell, Jennifer L. , Josephs, Keith A. , Bejanin, Alexandre , Murray, Melissa E. , Botha, Hugo , Schwarz, Christopher G. , Senjem, Matthew L. , Chételat, Gaël , Jack, Clifford R. , Boeve, Bradley F. , Knopman, David S. , Giannini, Caterina , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2019.06.4152 Get It

P4‐330: LONGITUDINAL BEHAVIOR OF BETA‐AMYLOID IN NEURODEGENERATIVE DEMENTIAS
Whitwell, Jennifer L. , Tosakulwong, Nirubol , Weigand, Stephen D. , Graff‐Radford, Jonathan , Ertekin‐Taner, Nilüfer , Lowe, Val J. , Josephs, Keith A. , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Botha, Hugo , Utianski, Rene L. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_27 | Pages: No page available

10.1016/j.jalz.2019.06.4000 Get It